Demonstration of the therapeutic potential of non-anaphylactogenic anti-ige antibodies in murine models of skin reaction, lung function and inflammation

International Archives of Allergy and Immunology

Volumn 113, Issue 1-3, 1997, Pages 231-235

  Heusser, Christoph H ^a   Wagner, Kathrin ^a   Bews, John P A ^a   Coyle, Anthony ^a   Bertrand, Claude ^a   Einsle, Karin ^a   Kips, Johan ^b   Eum, Seok Yong ^c   Lefort, Jean ^c   Vargaftig, Boris ^c  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c INSTITUT PASTEUR   (France)

Author keywords

Anti IgE; BHR; Bronchoconstriction; Eosinophil; IgE; Immunoregulation; Skin reaction

Indexed keywords

CD23 ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; OVALBUMIN; PENICILLIN G DERIVATIVE;

ALLERGIC ASTHMA; ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; EOSINOPHILIA; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG FUNCTION; LUNG INFILTRATE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SKIN MANIFESTATION;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; BRONCHOCONSTRICTION; EOSINOPHILS; IMMUNOGLOBULIN E; INFLAMMATION; MICE; MICE, INBRED BALB C; RATS; RECEPTORS, IGE; SKIN;

EID: 8244256660     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237555     Document Type: Article

References (23)

1. IIcusser CH, Bews J, Brinkmann V, Delespcsse G, Kilchherr E, Ledermann F, LcGros G, Wagner K: New concepts of IgE regulation, Int Arch Allergy Appl Immunol 1991;94:87-90.
2. Chang TW, Davis FM, Sun NC, Sun CRY, MacGlashan DW, Hamilton RG: Monoclonal antibodies specific for human IgE-producing B cells: A potential therapeutic for IgE-mediatcd allergic diseases, Biotechnology 1990:8:122-126.
3. Davis FM, Gossett LA, Pinkston KL, Liou RS, Sun LK, Kim YW, Chang NT, Chang TW, Wagner K, Bews J, Brinkmann V, Towbin H, Subramanian N, Heusscr CM: Can anti IgE be used to treat allergy? Springer Semin Immuno-patliol 1993:15:51-73.
4. Prcsta LG, Iahr SJ, Shields RL, Porter JP, Gorman CM, Fetidly BM, Jardieu PM: Humanization of an antibody directed against IgE, J Immunol 1993:151:2623-2632.
5. Shields R, Whether WR, Zioncheck K, O’Connell L, Prcsta LG, Thomas D, Saban R, Jardieu P: Inhibition of allergic reactions with antibodies to IgE, Int Arch Allergy Immunol, 1995: 107:308-312.
6. Magnusson CGM, Johansson SGO: Clinical significance of anti-lgE autoantibodies and immune complexes containing IgE, Clin Rev Allergy 1989:7:73-103.
7. Heusser CH, Wagner K, Brinkmann V, Severin-son E, Blaser K: Establishment of a memory in vitro murine IgE response to bcnzylpcnicillin and its resistance to suppression by anti-IL-4 antibody, Int Arch Allergy Immunol 1991:94: 87-90.
8. Coyle AJ, Wagner K, Bertrand C, Tsuyuki S, Bews J, HeusserCH: Central role of IgE in the induction of lung eosinophil infiltration and Th2 cell cytokine production: Inhibition by a non-anaphylactogcnic anti-lgE antibody, J Exp Med 1996:183:1303-1310.
9. Ovary Z, Caiazza S, Kojima S: PCA reactions with mouse antibodies in mice and rats, Int Arch Allergy Appl Immunol 1975;48:16-21.
10. Eum SY, Haile S, Lefort J, Iluerre M, Vargaftig BB: Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hypcr-IgE mice is accompanied by IL-5-de-pendent bronchial hyperresponsivencss, Proc Natl Acad Sei USA 1995:92:12290-12294.
11. Ball PE, Conroy MC, Hcusser CH, Davis JM, Conscience JF: Spontaneous in vitro malignant transformation of a basophil/mast cell line, Differentiation 1983:24:74-78.
12. Blaser K, Hcusser CH: The IgE antibody response to the phosphorylcholinc hapten, Int Rev Immunol 1987:2:93-115.
13. Barsumian EL, Isersky C, Petrino MG, Siraga-nian RP: IgE-induced histamine release from rat basophilic leukemia cell lines: Isolation of releasing and nonrclcasing clones, EurJ Immunol 1981:11:317-323.
14. Dombrowicz D, Flamand V, Brigman KK, Koller BL, Kinet JP: Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene, Cell 1993:75:969-976.
15. Ottgen HC, Martin TR, Wynshaw A, Deng C, Drazen JM, Leder P: Active anaphylaxis in IgE deficient mice, Nature 1994:370:367-370.
16. Haba S, Nisonoff A: Inhibition of IgE synthesis by anti-lgE: Role in long-term inhibition of IgE synthesis by neonatally administrated soluble IgE, Proc Natl Acad Sei USA, 1990:87:3363 3367.
17. Haak-Frendscho H, Robbins K, Lyon R, Shields R, Hooley J, Schoenhol TM, Jardieu P: Administration of an anti-lgF, antibody inhibits CD23 expression and IgE production in vivo, Immunology 1994:82:306-313.
18. Rabe KF, Morton BE, Dent G, Munoz NM, Wagner K, Leff AR, Magnussen H, Heusscr CH: Inhibition of allergen-induced contraction ofluiman airways in vitro by a monoclonal antihuman IgE antibody, Am J Respir Care Med 1995; 151: 215.
19. McGlashon D, Peters SP, Warner J, Lichtenstein L: Characteristics of human basophil sulfido-peptidc leukotricnc release, J Immunol 1986; 136:2231-2239.
20. Sherrill DL, Lebowitz MD, Haloncn M, Barbee RA, Burrows B: Longitudinal evaluation of the association between pulmonary function and total serum IgE, Am J Respir Crit Care Med 1995:152:98-102.
21. Postma DS, Bleeker ER, Amelung PJ, Holroyd KJ, Xu J, Panhuyscn Cl, Meyers DA, Levitt RC: Genetic susceptibility to asthma-bronchial hyperresponsivencss coinherited with a major gene for atopy, N Engl J Med 1995:333:894-900.
22. Come J, Djukanovic R, Botta L, Grandordy B, Gygax D, Hcusser C, Richardson W, Staehelin T, Davis F, Gordon W, Sun L, Wang G, Chang TW, Holgatc S: Safety, tolerability, and pharmacokinetics of a chimeric antibody against human IgE in atopic volunteers, Am J Respir Care Med 1996; 153:533.
23. Kolbinger F, Saldanha J, Hardmann N, Bendig M: Humanization of a mouse anti-human IgE antibody: A potential therapeutic for IgE-medi-atedallergies, Protein Eng 1993:6:971-980